| Pirfenidone in patients with rapidly progressive interstitial lung disease associated with clinically amyopathic dermatomyositis T Li, L Guo, Z Chen, L Gu, F Sun, X Tan, S Chen, X Wang, S Ye Scientific reports 6 (1), 33226, 2016 | 88 | 2016 |
| Paxlovid in patients who are immunocompromised and hospitalised with SARS-CoV-2 infection F Sun, Y Lin, X Wang, Y Gao, S Ye The Lancet infectious diseases 22 (9), 1279, 2022 | 53 | 2022 |
| CD4+CXCR4+ T cells as a novel prognostic biomarker in patients with idiopathic inflammatory myopathy-associated interstitial lung disease K Wang, J Zhao, Z Chen, T Li, X Tan, Y Zheng, L Gu, L Guo, F Sun, ... Rheumatology 58 (3), 511-521, 2019 | 51 | 2019 |
| Safety and efficacy of metformin in systemic lupus erythematosus: a multicentre, randomised, double-blind, placebo-controlled trial F Sun, HJ Wang, Z Liu, S Geng, HT Wang, X Wang, T Li, L Morel, W Wan, ... The Lancet Rheumatology 2 (4), e210-e216, 2020 | 42 | 2020 |
| Effects of metformin on disease flares in patients with systemic lupus erythematosus: post hoc analyses from two randomised trials F Sun, S Geng, H Wang, H Wang, Z Liu, X Wang, T Li, W Wan, L Lu, ... Lupus science & medicine 7 (1), e000429, 2020 | 33 | 2020 |
| Two distinct clinical phenotypes of pulmonary arterial hypertension secondary to systemic lupus erythematosus F Sun, Y Lei, W Wu, L Guo, K Wang, Z Chen, W Xu, X Wang, T Li, X Zhang, ... Annals of the Rheumatic Diseases 78 (1), 148-150, 2019 | 29 | 2019 |
| TET1 is an important transcriptional activator of TNFα expression in macrophages F Sun, I Abreu-Rodriguez, S Ye, S Gay, O Distler, M Neidhart, ... PLoS One 14 (6), e0218551, 2019 | 25 | 2019 |
| TMA secondary to SLE: rituximab improves overall but not renal survival F Sun, X Wang, W Wu, K Wang, Z Chen, T Li, S Ye Clinical rheumatology 37, 213-218, 2018 | 21 | 2018 |
| The performance of different anti-dsDNA autoantibodies assays in Chinese systemic lupus erythematosus patients J Zhao, K Wang, X Wang, T Li, L Guo, L Gu, Z Chen, F Sun, H Wang, J Li, ... Clinical rheumatology 37, 139-144, 2018 | 18 | 2018 |
| Safety and efficacy of the SGLT2 inhibitor dapagliflozin in patients with systemic lupus erythematosus: a phase I/II trial H Wang, T Li, F Sun, Z Liu, D Zhang, X Teng, L Morel, X Wang, S Ye RMD open 8 (2), e002686, 2022 | 15 | 2022 |
| Varicella zoster virus infections increase the risk of disease flares in patients with SLE: a matched cohort study F Sun, Y Chen, W Wu, L Guo, W Xu, J Chen, S Sun, J Li, Z Chen, L Gu, ... Lupus Science & Medicine 6 (1), e000339, 2019 | 14 | 2019 |
| Systemic lupus erythematosus gastrointestinal involvement: a computed tomography-based assessment Z Chen, J Zhou, J Li, Y Zhou, X Wang, T Li, L Gu, F Sun, W Wu, W Xu, ... Scientific Reports 10 (1), 6400, 2020 | 12 | 2020 |
| Major infections in newly diagnosed systemic lupus erythematosus: an inception cohort study H Wang, Y Zhou, L Yu, W Wu, L Zhao, S Geng, F Sun, D Zhang, N Shen, ... Lupus Science & Medicine 9 (1), e000725, 2022 | 11 | 2022 |
| Description and analysis of a novel subtype of the anti-synthetase syndrome characterized by frequent attacks of fever and systemic inflammation in a single-center cohort study S Sun, Z Chen, D Zhang, W Xu, W Wu, F Sun, L Gu, J Chen, J Li, T Li, ... Frontiers in Immunology 12, 729602, 2021 | 11 | 2021 |
| Rituximab or cyclosporin in refractory immune thrombocytopenia secondary to connective tissue diseases: a real-world observational retrospective study F Sun, J Chen, W Wu, S Geng, WW Xu, S Sun, Z Chen, L Gu, X Wang, T Li, ... Clinical rheumatology 39, 3099-3104, 2020 | 10 | 2020 |
| One-year renal outcome in lupus nephritis patients with acute kidney injury: a nomogram model F Sun, H Wang, D Zhang, F Han, S Ye Rheumatology 61 (7), 2886-2893, 2022 | 8 | 2022 |
| Attaining treat-to-target endpoints with metformin in lupus patients: a pooled analysis SY Fangfang Sun, Danting Zhang, Haiting Wang, Huijing Wang, Zhe Liu, Shikai ... Clin Exp Rheumatol, DOI: 10.55563/clinexprheumatol/7y5ku8, 2021 | 7* | 2021 |
| Low-dose belimumab for patients with systemic lupus erythematosus at low disease activity: protocol for a multicentre, randomised, double-blind, placebo-controlled clinical trial F Sun, W Huang, J Chen, L Zhao, D Zhang, X Wang, W Wan, SM Dai, ... Lupus Science & Medicine 9 (1), e000638, 2022 | 5 | 2022 |
| Mortality risk prediction in lupus patients complicated with invasive infection in the emergency department: LUPHAS score W Wu, J Ma, Y Zhou, C Tang, F Zhao, F Sun, W Xu, J Chen, S Ye, Y Chen Therapeutic Advances in Musculoskeletal Disease 11, 1759720X19885559, 2019 | 5 | 2019 |
| Primary hypertrophic osteoarthropathy with SLCO2A1 mutation in a Chinese patient successfully treated with etoricoxib F Sun, L Guo, S Ye JCR: Journal of Clinical Rheumatology 24 (3), 164-167, 2018 | 4 | 2018 |
